Consumers Warned About A Certain Brand of Chocolate Bars

Let’s talk about a pressing issue that’s recently come to light—something that could affect many chocolate lovers out there.

The Food and Drug Administration (FDA) has issued a serious warning against consuming “microdosing” chocolate bars made by Diamond Shruumz. This news has certainly raised some eyebrows, so let’s dive into the details.

On Friday, the FDA, along with the Centers for Disease Control and Prevention (CDC), America’s Poison Centers, and local and state partners, began investigating multiple illnesses linked to these chocolate bars.

Diamond Shruumz advertises its product as offering a “relaxed, euphoric experience” without containing psilocybin, the psychedelic compound found in certain mushrooms. Instead, they claim their bars contain a “proprietary nootropics blend” designed to enhance creativity and mood safely.

However, despite these claims, some consumers have reported severe health issues after eating these chocolate bars. According to the FDA, symptoms have included seizures, central nervous system depression (which involves loss of consciousness, confusion, and sleepiness), agitation, abnormal heart rates, significant changes in blood pressure, nausea, and vomiting.

So far, six individuals have been hospitalized due to these symptoms, although thankfully, no deaths have been reported.

Diamond Shruumz insists their products are free from psilocybin and other controlled substances. They promote their chocolate as a safe and enjoyable way to boost mood and creativity without any psychedelic effects. Despite their assurances, the FDA has strongly advised consumers to steer clear of buying, selling, or eating these bars until further notice.

The FDA and CDC are actively investigating to pinpoint the cause of these adverse reactions. They are also closely examining the safety of the ingredients listed in the product’s nootropic blend. This investigation is ongoing, and more information will likely emerge as the authorities dig deeper into the matter.